Drug intelligence / Profile preview

thiopental + propofol

Development stage
Unknown
Lead developer
Shiraz University of Medical Sciences
Modality
Small Molecules
Administration
Intravenous
01

Overview

Thiopental and propofol are intravenous anesthetic agents used for the induction and maintenance of general anesthesia. Thiopental is a short-acting barbiturate that acts as a positive allosteric modulator of the GABA-A receptor, increasing the duration of chloride channel opening. Propofol is a phenol derivative that also acts on the GABA-A receptor but increases the frequency of channel opening and can directly activate the receptor at high concentrations. This specific combination/comparison was evaluated by Shiraz University of Medical Sciences in a clinical study for patients undergoing cataract surgery to determine the effectiveness of thiopental induction followed by propofol maintenance versus propofol induction and maintenance, using Bispectral Index (BIS) monitoring to assess anesthesia depth.

Other names
thiopentalpropofolthiopental sodium
02

Targets

GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on thiopental + propofol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on thiopental + propofol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call